Brandi Roberts serves as Executive at Mast Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Brandi Roberts has executed 8 insider transactions totaling $36.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 3, 2024 involved receiving (via award) 3,165 shares valued at $0.
Brandi Roberts currently holds 23,165 shares of Mast Therapeutics, Inc. (MSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brandi Roberts has been a net buyer of MSTX stock. They have purchased $36.6K and sold $0 worth of shares.
Brandi Roberts's most recent insider trade was on Jul 3, 2024, when they sold 3,165 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 15, 2023 | TFFP | $5.0K | Purchase | 20,000 | $0.25 | Discretionary |
| Aug 13, 2019 | LCTX | $5.0K | Purchase | 5,000 | $1.01 | Discretionary |
| Jun 29, 2018 | RVA.AX | $7.5K | Purchase | 4,907.9 | $1.53 | Discretionary |
| Jan 22, 2018 | RVA.AX | $0 | Award | 50,000 | $N/A | Discretionary |
| Mar 27, 2015 | MSTX | $9.0K | Purchase | 18,000 | $0.50 | Discretionary |
| Mar 26, 2015 | MSTX | $10.0K | Purchase | 20,000 | $0.50 | Discretionary |